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Enteroviruses are among the most common viruses infecting humans and can cause
diverse clinical syndromes ranging from minor febrile illness to severe and potentially fatal
diseases. Enterovirus species C (EV-C) consists of more than 20 types, among which
the three serotypes of polioviruses, the etiological agents of poliomyelitis, are included.
Biodiversity and evolution of EV-C genomes are shaped by frequent recombination
events. Therefore, identification and characterization of circulating EV-C strains require
the sequencing of different genomic regions. A simple method was developed to
quickly sequence the entire genome of EV-C isolates. Four overlapping fragments were
produced separately by RT-PCR performed with generic primers. The four amplicons
were then pooled and purified prior to being sequenced by a high-throughput technique.
The method was assessed on a panel of EV-Cs belonging to a wide-range of types. It
can be used to determine full-length genome sequences through de novo assembly of
thousands of reads. It was also able to discriminate reads from closely related viruses in
mixtures. By decreasing the workload compared to classical Sanger-based techniques,
this method will serve as a precious tool for sequencing large panels of EV-Cs isolated in
cell cultures during environmental surveillance or from patients, including vaccine-derived
polioviruses.
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INTRODUCTION
The members of the Enterovirus species C (EV-C), genus Enterovirus, family Picornaviridae, are
non-enveloped viruses with a single positive strand RNA genome. The virions contain one copy
of the genome, which is about 7500 nucleotides in length and consists of two untranslated regions
(5′- and 3′-UTR) flanking a unique large open reading frame. The polyprotein encoded by this
open reading frame is first cleaved into three precursors (P1–P3) that are subsequently cleaved into
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functional proteins. P1 gives rise to the four structural capsid
proteins (VP1–VP4) while P2 and P3 generate non-structural
proteins involved in the viral cycle. Enteroviruses cause a
wide spectrum of human diseases, with clinical signs ranging
from mild febrile illness, such as the common cold, to severe
forms, such as acute haemorrhagic conjunctivitis, myocarditis,
encephalitis, and acute flaccid paralysis (Tapparel et al., 2013).
Currently, more than 20 types of EV-Cs have been identified
(Knowles et al., 2012), including the three serotypes of poliovirus
(PV-1 to −3) that can induce severe and potentially fatal
cases of poliomyelitis in humans. Typing of enteroviruses relies
on molecular characterization of the capsid-encoding region
(Blomqvist and Roivainen, 2016). For this purpose, many generic
assays were developed to amplify genomic fragments within
the VP4-, VP2-, or VP1-encoding regions by RT-PCR and to
sequence the resulting amplicons. The sequences of clinical or
field viruses can be compared to those of prototype strains in
order to determine their respective types.
Besides typing, molecular characterization of circulating EV-
Cs generally implies sequencing of untranslated or non-structural
genomic regions, or even full-length sequencing of the genome.
Indeed, recombination events between enteroviruses are known
to be very frequent, thus leading to complex ecosystems of co-
circulating viruses featuring mosaic genomes (Savolainen-Kopra
and Blomqvist, 2010; Combelas et al., 2011; Kyriakopoulou et al.,
2015). As recombination constitutes a powerful force that drives
enterovirus evolution, sequencing of different genomic regions
of isolates is crucial to detect recombination events. Such events
are revealed by incongruent clustering of genetic sequences
in phylogenetic trees, depending on the studied genomic
regions.
Generic assays have been developed to amplify non-structural
regions of EV genomes, particularly the 5′-UTR and the 2C-
and the 3D-encoding regions (Bessaud et al., 2008). These wide-
range assays can be used to characterize portions of the genome
of EV-Cs but determining the full-length genomic sequences
requires additional sequencing steps to bridge the gaps between
the sequences determined through generic assays. These steps
require the usage of specific primers that have to be designed
for each isolate and can be very labor-intensive when numerous
isolates of many types are studied.
In order to facilitate the full-length sequencing of EV-C
isolates, a simple method was developed, which allowed the
amplification of the whole genome by RT-PCR using four generic
primer pairs. Four overlapping fragments were produced by
performing four separate PCR reactions on cDNAs generated
through a single RT reaction. The four amplicons were then
pooled and purified prior to sequencing by high-throughput
sequencing methods.
The amplification step was assessed on a panel of prototype
and field strains whose genome had been previously sequenced
by the Sanger method. Sequencing data was analyzed by
mapping the reads against reference sequences and by de novo
assembly. This method was able to determine the full-length
genomic sequences of EV-C isolates with high sensitivity and to
discriminate the different genomic sequences within mixtures of
viruses.
TABLE 1 | Viruses used in the study.
Type Strain or Origin Cycle
isolate thresholda
CV-A1 Tompkins Prototype strain 14.5 ± 0.2
CV-A11 Belgium Prototype strain 16.6 ± 0.2
CV-A11 G9 Prototype strain 14.9 ± 0.7
CV-A11 66122 From Rakoto-Andrianarivelo et al. (2007) 15.6 ± 0.1
CV-A11 66990 From Rakoto-Andrianarivelo et al. (2007) 15.9 ± 0.1
CV-A13 Flores Prototype strain 15.7 ± 0.3
CV-A13 G13 Prototype strain 23.7 ± 0.1
CV-A13 67900 From Rakoto-Andrianarivelo et al. (2007) 17.1 ± 0.4
CV-A13 67001 From Rakoto-Andrianarivelo et al. (2007) 13.3 ± 0.2
CV-A17 G12 Prototype strain 13.8 ± 0.3
CV-A17 67591 From Rakoto-Andrianarivelo et al. (2007) 14.4 ± 0.9
CV-A17 68154 From Rakoto-Andrianarivelo et al. (2007) 15.2 ± 0.2
CV-A19 NIH-8663 Prototype strain 23.2 ± 1.0
CV-A20 Cecil Prototype strain 16.0 ± 0.1
CV-A20 IH35 Prototype strain 13.5 ± 0.4
CV-A20 Tulane Prototype strain 16.1 ± 0.1
CV-A21 Coe Prototype strain 17.7 ± 0.3
EV-C95 T08-083 From Sadeuh-Mba et al. (2013) 14.5 ± 0.5
EV-C99 68229 From Rakoto-Andrianarivelo et al. (2007) 11.5 ± 0.1
PV-1 Sabin Vaccine strain 15.6 ± 0.1
PV-2 Sabin Vaccine strain 17.4 ± 0.3
PV-3 Sabin Vaccine strain 20.9 ± 0.1
aCycle threshold values obtained by a pan-enterovirus real-time RT-PCR assay performed
on the extracted RNAs.
MATERIALS AND METHODS
Viruses
Twenty-two viruses were used for this study (Table 1). The
prototype viruses are available on the Pasteur Institute collection
(Centre de ressources biologiques de l’Institut Pasteur, Paris,
France). Field isolates originated from stool samples collected in
Madagascar in 2002 (Rakoto-Andrianarivelo et al., 2005, 2007)
and in Chad in 2008–2009 (Sadeuh-Mba et al., 2013). The whole
genomic sequence of these isolates were previously determined
by the Sanger method (Bessaud et al., 2011).
All work with infectious viruses was carried out in a BSL-
2 facility. All viruses were grown in HEp-2c cell monolayers in
DMEM supplemented with 2% fetal calf serum and 2 mM L-
glutamine at 37◦C, except coxsackievirus (CV) A1 Tompkins and
CV-A19 NIH-8663, see below. These latter cannot be propagated
in cell lines but can infect sucklingmice. RNA of these two viruses
was extracted from brains of mice inoculated intracerebrally.
These brains were retrieved from the laboratory collection and
no mice were used during this study. Brains were crushed in PBS
before RNA extraction.
Sequence Analysis and Primer Design
EV-C full-length nucleotide sequences retrieved from the
GenBank database were aligned using CLC Main Workbench
7.6.4 software (CLC bio). Eight degenerated primers were
designed to target conserved genomic regions (Table 2).
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TABLE 2 | Primers used in this study.
Step Name 5′ →3′ sequence Genome
positiona
cDNA
synthesis
heptaN NNNNNNN
PCR C004 TTAAAACAGCYYKDGGGTTG 1–20
C005 CCGAATYAAARRAAAATTTACCC 7437–7415
C008 CARTTYAAGASCAARCAYCG 4459–4478
C009 ACCATYTGRCARAANARYTTCA 4703–4682
C018 ATGYTNGGNACNCAYNTNATHTGGGA 2212–2237
C019 CCYTGYTCCATNRCYTCHTCYTC 3833–3811
C021 TCDGGNARYTTCCACCACCA 1205–1186
C022 GARGCNTGYGGDTAYAGYGA 967–986
aRelative to PV-2 strain Sabin.
RNA Extraction
Viral RNA was extracted from 250 µL of culture supernatants or
clarified brain extracts using the High Pure Viral RNA kit (Roche
Diagnostics, Meylan, France), following the manufacturer’s
instructions.
In order to check the RNA extraction step, a one-step real-
time RT-PCR assay was performed on extraction products using
a pan-enterovirus generic assay previously described (Monpoeho
et al., 2000).
Synthesis of the Four Overlapping
Amplicons by 2-Step RT-PCR
For each virus, four overlapping DNA fragments were produced
by RT-PCR (Figure 1). cDNA synthesis was performed as
previously described (Bessaud et al., 2008). The reaction mixture
contained 5 µL of purified viral RNA, 2 µL of 5X First-Strand
Buffer, 0.01 M dithiothreitol (1 µL), 100 ng of the random
primers heptaN (1 µL), 10 nmol of each dNTP (1µL of a 10mM
mixture), and 100 U of SuperScript II (0.5µL). The RT reaction
mixture was incubated at 25◦C for 10min, 42◦C for 45min and
95◦C for 5min.
The cDNA was then used as a template for amplification in
four PCRs carried out in a final volume of 50µL that included
5µL of 10X PCR Buffer w/oMgCl2, 1.5mMofMgCl2, 10 nmol of
each dNTP, 50 pmol of each primer, 2µL of cDNA, and 2.5 U of
Platinum Taq DNA polymerase (Invitrogen). The thermocycler
profile was 2min at 94◦C followed by 30 cycles of 30 s at 94◦C,
30 s at 55◦C, and 3min at 72◦C.
Ten microliters of each PCR product were analyzed on
ethidium bromide-stained agarose gels. For each virus, the four
PCR products were pooled, purified on silica columns (Wizard
SVGel and PCRClean-Up System, Promega) and eluted in 30µL
of water. No purification of the amplicons was performed by gel-
excision, even when additional bands were detected on ethidium
bromide-stained agarose gels.
Assay Sensitivity
The sensitivity of the assay was evaluated using serial three-
fold dilutions of a cell culture supernatant infected by CV-
A13 isolate 67001 whose titer was determined according to
the WHO standard protocol (Anonymous, 2004). To maintain
the same amount of cellular nucleic acids across dilutions,
dilutions were prepared using a supernatant of confluent non-
infected HEp-2c cell monolayer that was frozen and thawed twice
and then clarified by centrifugation. RNA was extracted from
250µL of each dilution and subjected to real-time RT-PCR as
described in Section RNA Extraction, and amplified by RT and
PCR as described in Section Synthesis of the Four Overlapping
Amplicons by 2-Step RT-PCR.
Detection of Virus Mixtures
Four mixtures were prepared using cell culture supernatants of
CV-A13 isolates 67900 and 67001 whose titer was determined
according to the WHO standard protocol (Anonymous, 2004).
Titers were adjusted to 107.5 TCID50.mL
−1 before mixing.
Different mixtures were prepared with 67900/67001 titer ratios
ranging from 1:1 to 10:1. RNAwas extracted from 250µL of these
mixtures and subjected to RT and PCR as described in Section
Synthesis of the Four Overlapping Amplicons by 2-Step RT-PCR.
Sequencing Process
DNA concentration of the purified RT-PCR products was
determined by using a VarioskanLux (ThermoScientific).
Libraries were built using 1 ng of DNA with the Nextera XT
DNA Library Preparation kit in a SureCycler 8800 thermocycler
(Agilent). After purification on AMPure beads (Beckman),
the libraries were controlled using the High Sensitivity D1000
assay (Agilent) on a TapeStation 2200. Sizing was achieved by
electrophoresis on a PippinPrep System with the PippinPrep
kit CDF1510 (Ozyme). Finally, the libraries were quantified
using the KAPA Quantification kit on a LightCycler 96 System
(Roche). Sequencing was performed on a NextSeq500 with the
HighOutput or MidOutput kits. All kits were used following
manufacturer’s instructions.
Data Analysis
Trimming
Reads were demultiplexed followed by the removal of tags and
adaptors. After importation in CLC Genomics Workbench 8.5
(CLCbio), reads were trimmed using the following parameters:
Trim quality score limit = 0.01; Trim ambiguous nucleotides
with Maximum number of ambiguities = 1. To avoid the
presence of primer sequences in the reads, the 26 5′- and
3′-terminal nucleotides were removed. After trimming, reads
shorter than 50 nucleotides were discarded.
Mapping of the Reads to a Reference
For each sample, the trimmed reads were mapped against the
reference sequence of the corresponding virus. The sequences
used as references were the sequences previously determined by
the Sanger method. The entire genome of all field isolates were
previously sequenced in our laboratory (Bessaud et al., 2011); for
prototype strains, the sequences used as references were retrieved
from the Genbank database. Mapping was achieved with CLC
Genomics Workbench 8.5 by using the following parameters:
Mismatch cost= 10; Insertion cost = 3; Deletion cost = 3;
Length fraction= 0.5; Similarity fraction= 0.95.
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FIGURE 1 | Schematic representation of the locations of the primers used for the PCR step. The upper scheme represents the organization of the
enterovirus genomic RNA. Arrows indicate the sites targeted by the primers. The RT-PCR products are colored according to the corresponding primer pair.
De novo Assembly
For each sample, the trimmed reads were assembled without
any reference using CLC Genomics Workbench 8.5 with the
following parameters: Mismatch cost = 2; Insertion cost = 2;
Deletion cost = 2; Length fraction = 0.5; Similarity fraction =
0.95.
All contigs longer than 200 nucleotides were submitted to
BLAST analysis (Mount, 2007). Virus contigs were compared
with the reference sequence of the corresponding virus
determined by the Sanger method through alignment.
RESULTS
Sequence Analysis and Primer Design
Eight degenerated primers were designed to target nucleotide
sequences that were conserved among EV-Cs (Figure 1). C004
and C005 target the extremity of the 5′ and 3′ non-coding
region, respectively. C018, C019, and C008match with conserved
regions already targeted by pan-EV molecular assays (Caro
et al., 2001; Nix et al., 2006; Bessaud et al., 2008) within the
VP3 gene, at the 2A/2B junction, and within the 2C cis-acting
replication element (Cordey et al., 2008), respectively. The three
other primers, C021, C022, and C009 match with VP2 and 2C
sequences.
The primer pairs C004/C021, C022/C019, C018/C009, and
C008/C005 were used to produce four overlapping DNA
fragments (fragments A–D) that span the entire viral genome.
Fragments ranged from ∼1200 to ∼3000 nucleotides in
length. Overlapping regions were approximately 240-nt-long for
fragments A and B and fragments C and D (Figure 1). The
overlapping region for fragments B and C was longer than 1600
nt.
RT-PCR Amplification
The four primer pairs C004/C021, C022/C019, C018/C009,
and C008/C005 were tested on prototype and field strains
representative of 12 EV-C types (Table 1). This panel included
the three PV serotypes and non-polio types commonly isolated
during environmental or epidemiological surveillance, such as
CV-A11, CV-A13, CV-A17, CV-A20, CV-A21, and EV-C99.
One field strain belonged to the type EV-C95 that was recently
discovered (Junttila et al., 2015) and of which few isolates were
reported in Africa. The panel also included the prototype strains
of CV-A1 and CV-A19, two types that are uncultivable on cell
lines (Brown et al., 2003). Overall, 22 viruses were used to assess
the efficiency of the primers. After RNA extraction, detection of
viral RNA by real-time RT-PCR resulted in cycle threshold values
ranging from 11.5± 0.1 to 23.7± 0.1 (Table 1).
Following the RT step with random primers performed on
viral RNA extracted from infected cell culture supernatants (or
from crushed brains of mice infected by CV-A1 or CV-A19),
the PCR performed with the four primer pairs produced gel
bands at the expected size for all the viruses (data not shown).
Some additional bands were also observed for certain RT-PCR
products. Among our panel, CV-A19 NIH-8663 RNA gave the
weakest bands on ethidium bromide-stained gel after the RT-
PCR step. It is not possible to exclude the hypothesis that the
four primer pairs had a low efficiency in amplifying the genome
of this virus through PCR because of mismatches. Nonetheless,
since the RNA of this virus was extracted from a mouse brain
collected more than 20 years ago, this result is more likely due to
the low amount of full-length virus RNA in this sample.
Results of Sequencing
The products of RT-PCR amplification of non-polio EV were
sequenced by Illumina technology. Due to French regulations
relating to PV containment, the sequencing platform was not
allowed to handle the PV RT-PCR products.
For each sample, the four RT-PCR fragments were produced
separately and then pooled prior to purification. Sequencing
resulted in a list of reads of which most were ∼100 nucleotide-
long after trimming. Because all of the samples were not
sequenced during the same run, the number of reads varied from
sample to sample. Thus, the number of reads after trimming
ranged from 76,802 to 714,322 (Table 3).
Bioinformatics Analysis
Raw data generated by high-throughput sequencing was
analyzed by two different methods commonly used for virus
characterization.
The first method consists in mapping the reads against a
reference sequence. This method can be used to re-sequence
isolates or to detect single-point mutations that appear when a
given virus is propagated under different conditions (e.g., various
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TABLE 3 | Overview of the results of the bioinformatics analysis performed on sequencing data.
Strain or isolate Total number of reads Mapping on reference sequence De novo assembly
Number of mapped Average Number of reads in Number of
reads (%a) depth the virus contig (%b) host contigs
CV-A1
Tompkins 391,846 380,207 (97%) 7032 379,991 (96%) 200
CV-A11
Belgium 373,748 337,637 (90%) 6214 337,708 (90%) 232
G9 121,080 119,260 (98%) 2310 120,181 (99%) 16
66122 76,802 76,342 (99%) 982 76,290 (99%) 3
66990 121,784 114,961 (94%) 2277 120,712 (99%) 10
CV-A13
Flores 88,094 86,883 (97%) 1608 81,912 (93%) 6
G13 101,372 98,056 (96%) 1902 100,746 (99%) 12
67900 175,426 174,488 (99%) 3382 154,526 (88%) 1
67001 189,890 185,674 (97%) 3689 188,303 (99%) 0
CV-A17
G12 554,763 553,436 (99%) 10,404 553,221 (99%) 28
67591 421,668 367,691 (87%) 4741 365,019 (87%) 197
68154 84,786 83,710 (98%) 1548 83,251 (98%) 14
CV-A19
NIH-8663 374,976 153,262 (40%) 2958 152,980 (40%) 783
CV-A20
Cecil 619,194 616,252 (99%) 11,525 615,858 (99%) 59
IH35 698,498 630,711 (99%) 11,657 632,064 (99%) 39
Tulane 714,322 712,310 (99%) 13,336 712,445 (99%) 21
CV-A21
Coe 570,328 525,606 (92%) 9608 565,659 (99%) 115
EV-C95
T08-083 96,460 96,059 (99%) 1776 96,110 (99%) 7
EV-C99
68229 575,410 573,084 (99%) 10,435 572,958 (99%) 19
a These percentages indicate the proportion of total reads that matched with the reference sequence.
b These percentages indicate the proportion of total reads that were included in the virus contig through de novo assembly.
host species, various cell lines or presence of antiviral molecules,
for example).
The second method consists in constructing contigs through
de novo assembly (i.e., without any reference sequence to
drive the assembly). This method can be used to determine
the full-length sequence of viruses isolated from clinical or
environmental samples.
Mapping on Reference Sequence
For each sample, reads were mapped against the corresponding
sequence previously determined by the Sanger method (Table 3).
For all samples except one, more than 87% of the reads mapped
against the reference sequence. The only exception was CV-A19
NIH-8663, a non-cultivable virus, in which only 40% of the reads
mapped to the reference.
For all samples, the reference sequence was fully covered
without any gaps (breadth of coverage >99.0%). The breadth
of coverage never reached 100.0% because the sequences
corresponding to the outer primers C004 and C005 and the few
nucleotides located downstream C005 were absent in the final
contig.
Average depth of coverage, which is the average number of
times a base is sequenced, was very high (>980) but varied
greatly from sample to sample (Table 3), depending on the total
number of reads (correlation coefficient>0.999). Coverage depth
was heterogeneous along the mapping (Figure 2) but was high
enough to deduce an unambiguous consensus sequence even for
samples with a low number of reads (CV-A11 66122 or CV-
A17 68154 for instance) or a low proportion of mapping reads
(CV-A19 NIH-8663).
The consensus sequences of field strains deduced from
mapping were compared to the consensus sequences
determined by the Sanger method using RNA extracted
from the same cell culture supernatants. For each virus,
the two consensus sequences were identical indicating that
high-throughput sequencing did not introduced nucleotide
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FIGURE 2 | Coverage depth observed for three samples after mapping on their respective reference sequence. Coverage depth is the number of times a
base is sequenced. On the right side of each graph, the minimum and maximum coverage depth values are indicated.
changes in the consensus sequences compared to the Sanger
method.
De novo Assembly
In order to assess the ability of the method to determine full-
length sequences of the original isolates, the trimmed reads of
each sample were assembled without using a reference.
For all samples, the de novo assembly tool of CLC Genomics
Workbench succeeded in assembling the virus genome into a
unique contig that covered the entire genome between the outer
primers C004 and C005. The number of reads included in the
final full-length contigs was virtually similar to the number of
reads previously found to map against the reference (Table 3).
The consensus sequence deduced from de novo assembly was
identical to the consensus sequence already determined by
mapping.
For most samples, besides the viral contigs, de novo assembly
produced additional contigs that were identified as human
sequences (or mouse sequences for CV-A1 and CV-A19 samples)
by BLAST analysis. These contigs were from non-specific
amplification of cellular nucleic acids during the RT-PCR
process or from contamination of the viral RNA with cellular
DNA during extraction. The number of such contigs varied
tremendously from sample to sample, ranging from 0 to 783
(Table 3). Nonetheless, contaminating nucleic acids did not
compromise the proper assembly of the viral genome, even for
the CV-A19 sample that contained mostly non-viral reads.
Sensitivity of the Assay
In order to evaluate the sensitivity of the assay, three-fold serial
dilutions of a CV-A13 67001 supernatant at 107.8 TCID50.mL
−1
were prepared. After RNA extraction, detection of viral RNA by
real-time RT-PCR showed positive results for extracts from the
first 15 dilutions (Table 4).
The 2-step RT-PCR assays using C004/C021, C022/C019,
C018/C009, and C008/C005 were tested on these extracts. The
four primer pairs were able to generate detectable amplicons for
RNA extracted from the undiluted supernatant and from the first
four dilutions (Figure 3). Since ethidium bromide-stained gels
have a detection limit of few nanograms of DNA per band, the
absence of visible bands after the amplification of the highest
dilutions does not indicate necessarily that no amplicons were
generated for these dilutions. Therefore, all the RT-PCR products
were investigated through high-throughput sequencing.
After pooling and purification, the RT-PCR products of each
dilution were sequenced during the same run. The total number
of reads varied from sample to sample, from 88,930 to 316,336
(Table 4). In the sample from the undiluted supernatant, 99.9%
of reads mapped against the reference sequence. As expected this
proportion decreased when the dilution factor increased but even
the samples from the highest dilutions contained a few hundred
reads from the virus genome. The non-mapped reads were from
cellular nucleic acids. For the six last samples (dilution factor
≥ 310), the number of virus reads was too low to reconstitute
the full-length genome sequence through de novo assembly. By
contrast, de novo assembly succeeded in building the full-length
genome for all samples with dilution factor ≤ 39, including the
last one in which only 2.5% of the reads were from the virus.
For this sample, the coverage depth ranged from 5 to 95 along
the contig (average of 28). In spite of this relatively low depth,
the contig sequence generated for this sample was identical to the
Sanger consensus sequence.
These results demonstrated that the method was able to
generate full-length sequences of EV-C isolates from a few
thousand reads and indicated that sequencing can be attempted
even in the absence of detectable bands on agarose gels.
Detection of Mixtures
Supernatants of cell cultures inoculated with clinical and
environmental samples often contain mixtures of enteroviruses.
In order to determine whether the method was able to sequence
mixtures by assembling properly different viral contigs, four
mixtures of viruses were prepared by mixing cell culture
supernatants of two viruses, 67900 and 67001. These two viruses
belong to the same serotype (CV-A13) and display together a
nucleotide identity of 83%. The four mixtures contained the same
volume of 67900 supernatant but different volumes of 67001
supernatant (Table 5). Thus, the titer ratios ranged from 1:1
to 10:1.
For the four mixtures, de novo assembly generated separate
contigs for reads from 67900 and from 67001. As expected, the
proportion of reads included in the 67900 contigs increased from
mixture 1 to mixture 4 while the proportion of reads in the
67001 contigs decreased (Table 5). Nonetheless, even in mixture
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TABLE 4 | Evaluation of the sensitivity of the assay.
Dilution Viral titer RT-PCR cycle DNA concentration Number of Number of reads mapping Construction of a full-length
factor (TCID50.mL
−1) threshold (ng.µL−1) b reads against the reference (% c) contig through de novo assembly
30 107.8 16.2 ± 0.1 >200.0 197,190 196,993 (99.9%) Yes
31 107.3 17.9 ± 0.4 90.4 143,770 143,125 (99.5%) Yes
32 106.8 20.1 ± 0.4 76.7 140,554 138,103 (98.2%) Yes
33 106.4 21.6 ± 0.2 18.7 112,070 104,730 (93.4%) Yes
34 105.9 23.3 ±0.1 6.8 190,346 172,273 (90.5%) Yes
35 105.4 25.1 ± 0.1 5.5 316,336 218,511 (69.1%) Yes
36 104.9 26.7 ± 0.1 3.9 216,594 117,302 (54.1%) Yes
37 104.5 28.4 ± 0.2 3.4 117,920 48,054 (27.0%) Yes
38 104.0 30.0 ± 0.2 3.8 130,334 14,828 (11.3%) Yes
39 103.5 31.6 ± 0.1 2.8 88,930 2282 (2.5%) Yes
310 103.0 33.4 ± 0.2 2.5 119,950 1109 (0.9%) No
311 102.6 35.2 ± 0.6 3.1 104,470 511 (0.4%) No
312 102.1 36.1 ± 0.3 2.7 124,876 297 (0.2%) No
313 101.6 37.5 ± 0.6 1.1 105,656 208 (0.2%) No
314 101.1 > 38.0a 1.5 176,260 314 (0.2%) No
315 100.6 > 39.0a 1.1 111,890 228 (0.2%) No
aOnly one well of the triplicate assay showed a detectable increase in fluorescence.
bAfter pooling of the four RT-PCR products and purification, the DNA concentration was measured on a VarioskanLux spectrophotometer.
cThese percentages indicate the proportion of total reads that matched with the reference sequence.
4, which contained 10-fold less starting 67001 RNA compared to
mixture 1, the method was able to properly generate a full-length
contig corresponding to the expected sequence of 67001.
These results demonstrated that, by using the parameters
indicated in Section De novo Assembly, the stringency of the
de novo bioinformatics analysis was high enough to allow the
segregation of the reads into separate contigs.
DISCUSSION
High-throughput sequencing techniques constitute a powerful
tool for the study of viruses (Quiñones-Mateu et al., 2014;
Nelson and Hughes, 2015). By allowing concomitant sequencing
of millions of DNA fragments, they allow rapid sequencing of
a great number of samples and in-depth characterization of
minority genomic variants. The aim of this study was to develop a
convenient method allowing the whole sequencing of the genome
of EV-C isolates by using high-throughput sequencing.
Different strategies have been reported to copy viral genomic
RNAs into DNA fragments that can be subsequently sequenced
by high-throughput techniques.
Some strategies are based on random amplification using
non-specific primers (Berthet et al., 2008; Djikeng et al., 2008).
These strategies generally lead to the generation of DNA libraries
that mainly consist of non-viral sequences, thus decreasing the
amount of relevant reads obtained by sequencing. Reducing
the amount of unwanted reads requires the use of additional
procedures to physically enrich the samples for viral RNAs (Hall
et al., 2014) or to limit the amplification of host nucleic acids (Ge
et al., 2015). Whole sequencing of virus RNA genomes amplified
by random primers can also be impaired by the relatively low
amplification rate of some genomic regions, which can lead to
gaps in the genomic sequences (Rosseel et al., 2013).
Alternate strategies are based on primers that specifically
target the viral RNAs to be sequenced. Such strategies have
been already reported to sequence several positive-strand RNA
viruses, including enterovirus A71 (Wright et al., 2011; Baronti
et al., 2015; Cruz et al., 2016; Thomson et al., 2016). In our
experiments, using EV-C-targeting primers rather than random
primers limited the number of reads from cellular nucleic acids:
the proportion of reads from viral origin was higher than 90%
for most samples. The method was thus sensitive enough to
determine full-length genomes through de novo assembly from
only a few thousand reads.
The four primer pairs were efficiently tested on viruses
belonging to EV-C types commonly isolated during
epidemiological studies, including the three serotypes of
PV. They also amplified CV-A1 and CV-A19, which were
more closely related to EV-C types recently identified, such as
EV-C113 and EV-C116 (Tokarz et al., 2013). Since the primers
were designed from an alignment comprising the sequences
of all currently known EV-C types, they are likely to be used
successfully to amplify any EV-Cs. We cannot exclude that these
primers are also able to amplify genomic sequences of viruses
closely related to EV-Cs. In particular, the primer C008 targets
the cis-acting replication element that is highly conserved among
EV-As, -Bs, -Cs, and –Ds (Cordey et al., 2008). Reads from EV-
As, -Bs, or –Ds, or even rhinoviruses could thus be found in the
sequencing data generated from EV-Cs cell cultute supernatants
co-infected by members of these species. Nonetheless, as our
bioinformatics analyses was stringent enough to discriminate
reads from two EV-Cs belonging to the same type, they are
likely to discriminate reads from more divergent viruses, thereby
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FIGURE 3 | Sensitivity of the different primer pairs on CV-A13 67001 RNA extracted from three-fold serial dilutions. The DNA size scale, expressed in base
pairs (bp), is indicated on the left side of the gels.
TABLE 5 | Results obtained after sequencing and de novo assembly of mixtures of two viruses, CV-A13 67900 and CV-A13 67001.
Viral titer (log10 TCID50) Total number of reads De novo assembly
67900 67001 Ratio 67900 67001
Reads (%a) Average depth Reads (%b) Average depth
7.5 7.5 1:1 267,226 84,674 (31%) 1540 178,860 (66%) 3396
7.5 7.2 2:1 224,848 94,097 (41%) 1689 121,239 (53%) 2313
7.5 6.9 4:1 236,342 129,959 (54%) 2105 104,977 (44%) 1999
7.5 6.5 10:1 147,338 98,121 (66%) 1892 38,977 (26%) 740
aThese percentages indicate the proportion of total reads that were included in the CV-A13 67900 contig through de novo assembly.
bThese percentages indicate the proportion of total reads that were included in the CV-A13 67001 contig through de novo assembly.
preventing the generation of contigs made of reads from viruses
belonging to different species.
Our method was able to generate sequencing data even when
no bands were observed on agarose gel after the RT-PCR step.
This is a great advantage compared to Sanger-based sequencing
that requires substantial amounts of DNA. Since the sensitivity of
high-throughput sequencing depends as much on the sequencing
depth (i.e., the total number of reads obtained for a given sample)
as it does on the amount of virus genome copies in the sample,
increasing the sequencing depth would overcome the low yield of
RT-PCR amplification that could be observed for some samples.
Another advantage of high-throughput sequencing compared to
Sanger-based technics is that no gel-purification of the RT-PCR
products was required, even in the presence of contaminating
bands. In case of numerous samples to be analyzed, the RT-PCR
products could be purified faster by using ultrafiltration-based
or silica-based 96-well plates rather than individual silica-based
columns.
For all samples, the coverage depth was heterogeneous
along the genome. Heterogeneous coverage depths are often
observed after high-throughput sequencing, partly because of the
processing of the samples (Head et al., 2014; van Dijk et al.,
2014). Thus, biases can be introduced by the random shearing
of the DNA being sequenced (Poptsova et al., 2014) and by
the PCR amplification performed during the library preparation
(Aird et al., 2011). After these steps, some genomic regions
can be overrepresented whereas others are underrepresented
in the final libraries. Therefore, the coverage depth along the
genome does not reflect necessarily the relative abundance
of DNA amplicons in the original sample. However, in our
experiments, the low coverage depth observed in some genomic
regions did not impair the generation of the full-length consensus
sequence of the corresponding genomes through de novo
assembly.
In conclusion, we developed a set of generic primers for the
synthesis of RT-PCR products that span the whole genome of
EV-C isolates. This method was evaluated by using a panel of
viruses already characterized by Sanger-based methods to allow
the comparison of the sequences generated by our technique
with those obtained previously. For de novo assembly, the raw
data were analyzed in real conditions, i.e., with no reference to
the sequences already obtained by Sanger-based methods. After
assembly, the consensus sequences generated in this way were
identical to the Sanger consensus sequences.
In this work, the RT-PCR products were sequenced by
the Illumina sequencing technology but could be sequenced
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on any high-throughput sequencing platform. Thus, the
sequencing of DNA amplicons covering the whole genome of
enterovirus A71 isolates on an Ion Torrent Personal Genomic
Machine System was previously reported (Baronti et al.,
2015).
This method will serve as a multipurpose tool for laboratories
involved in the enterovirus surveillance. It could be used to
quickly determine full-length genomic sequences of EV-Cs
isolated in cell cultures during environmental surveillance or
from patients. In particular, characterization of the genome
of vaccine-derived PV, which generally display recombinant
genomes made of PV and non-PV genetic sequences (Combelas
et al., 2011), could be achieved quickly. The method could also
be used to get the full-length sequences of EV-Cs belonging to
uncharacterized collections, for example those constituted by the
laboratories involved in diagnosis or environmental surveillance
(Zaidi et al., 2016). Analyzing large panels of full-length EV-C
genomes originating from such collections would help to describe
the recombination events that occur between co-circulating
viruses and to better understand how recombination drives EV-C
evolution.
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